Business Context and Reporting Period
This Form 6-K filing by Innate Pharma S.A. is dated June 17, 2025. The report serves as a vehicle to disseminate a press release (Exhibit 99.1) issued on the same date. The registrant is a foreign private issuer based in Marseille, France, and files annual reports under Form 20-F.
Financial Metrics
The filing text provided does not contain specific financial data. No values for revenue, profit, cash flow, margins, debt, or liquidity are disclosed in this document.
Material Changes
The filing text does not provide information regarding material changes versus prior comparable periods. The document consists solely of the cover page and exhibit index.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, risks, contingencies, and unusual items are not detailed in the provided text. The filing references a press release (Exhibit 99.1) which likely contains these details, but the content of that release is not included in the input.
Key Facts for Investor Verification
- Verify the content of the press release dated June 17, 2025 (Exhibit 99.1), as the specific news or financial updates are not summarized in the cover document.
- Confirm the company's current cash position and runway, as no liquidity figures are present in this filing.
- Review the latest Form 20-F for the most recent audited financial statements, as this 6-K does not include updated financial tables.